Jorge Mera, MD

Director of Infectious Diseases
Cherokee Nation Outpatient Health Center
Tahlequah, Oklahoma, United States

Gilead Sciences, Inc (Consultant, Study Investigator (payment to employer not self))

Presentation(s):

• LB1 - Remdesivir for the Treatment of High-Risk Non-Hospitalized Individuals With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

  Thursday, September 30, 2021
  5:15 PM - 5:30 PM EDT